|
1
|
Balata H, Fong KM, Hendriks LE, Lam S,
Ostroff JS, Peled N, Wu N and Aggarwal C: Prevention and early
detection for NSCLC: Advances in thoracic oncology 2018. J Thorac
Oncol. 14:1513–1527. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xia C, Dong X, Li H, Cao M, Sun D, He S,
Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China
and United States, 2022: profiles, trends, and determinants. Chin
Med J (Engl). 135:584–590. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niu FY, Zhou Q, Yang JJ, Zhong WZ, Chen
ZH, Deng W, He YY, Chen HJ, Zeng Z, Ke EE, et al: Distribution and
prognosis of uncommon metastases from non-small cell lung cancer.
BMC Cancer. 16:1492016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu Y, Feit N, Huang Y, Xu W, Zheng S and
Li X: Gastrointestinal metastasis of primary lung cancer: An
analysis of 366 cases. Oncol Lett. 15:9766–9776. 2018.PubMed/NCBI
|
|
6
|
Yoshimoto A, Kasahara K and Kawashima A:
Gastrointestinal metastases from primary lung cancer. Eur J Cancer.
42:3157–3160. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Neeman E, Gresham G, Ovasapians N,
Hendifar A, Tuli R, Figlin R and Shinde A: Comparing physician and
nurse eastern cooperative oncology group performance status
(ECOG-PS) ratings as predictors of clinical outcomes in patients
with cancer. Oncologist. 24:e1460–e1466. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barta JA, Powell CA and Wisnivesky JP:
Global epidemiology of lung cancer. Ann Glob Health. 85:82019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McNeill PM, Wagman LD and Neifeld JP:
Small bowel metastases from primary carcinoma of the lung. Cancer.
59:1486–1489. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hung TI, Chu KE, Chou YH and Yang KC:
Gastric metastasis of lung cancer mimicking an adrenal tumor. Case
Rep Gastroenterol. 8:77–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jevremovic V: Is gastrointestinal
metastasis of primary lung malignancy as rare as reported in the
literature? A comparison between clinical cases and post-mortem
studies. Stud Oncol Hematol Rev. 12:51–57. 2016.
|
|
15
|
Yamada H, Akahane T, Horiuchi A, Shimada
R, Shibuya H, Hayama T, Nozawa K, Ishihara S, Matsuda K and
Watanabe T: A case of lung squamous cell carcinoma with metastases
to the duodenum and small intestine. Int Surg. 96:176–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Janež J: Acute intestinal obstruction due
to metastatic lung cancer-case report. J Surg Case Rep.
2017:rjx0312017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di JZ, Peng JY and Wang ZG: Prevalence,
clinicopathological characteristics, treatment, and rognosis of
intestinal metastasis of primary lung cancer: A comprehensive
review. Surg Oncol. 23:72–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang CJ, Hwang JJ, Kang WY, Chong IW, Wang
TH, Sheu CC, Tsai JR and Huang MS: Gastro-intestinal metastasis of
primary lung carcinoma: Clinical presentations and outcome. Lung
Cancer. 54:319–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue C, Hu Z, Jiang W, Zhao Y, Xu F, Huang
Y, Zhao H, Wu J, Zhang Y, Zhao L, et al: National survey of the
medical treatment status for non-small cell lung cancer (NSCLC) in
China. Lung Cancer. 77:371–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim SY, Ha HK, Park SW, Kang J, Kim KW,
Lee SS, Park SH and Kim AY: Gastrointestinal metastasis from
primary lung cancer: CT findings and clinicopathologic features.
AJR Am J Roentgenol. 193:W197–W201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lardinois D, Weder W, Roudas M, von
Schulthess GK, Tutic M, Moch H, Stahel RA and Steinert HC: Etiology
of solitary extrapulmonary positron emission tomography and
computed tomography findings in patients with lung cancer. J Clin
Oncol. 23:6846–6853. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stinchcombe TE, Socinski MA, Gangarosa LM
and Khandani AH: Lung cancer presenting with a solitary colon
metastasis detected on positron emission tomography scan. J Clin
Oncol. 24:4939–4940. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rossi G, Marchioni A, Romagnani E,
Bertolini F, Longo L, Cavazza A and Barbieri F: Primary lung cancer
presenting with gastrointestinal tract involvement:
Clinicopathologic and immunohistochemical features in a series of
18 consecutive cases. J Thorac Oncol. 2:115–120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakai H, Egi H, Hinoi T, Tokunaga M,
Kawaguchi Y, Shinomura M, Adachi T, Arihiro K and Ohda H: Primary
lung cancer presenting with metastasis to the colon: A case report.
World J Surg Oncol. 10:1–5. 2012. View Article : Google Scholar
|
|
25
|
Goh BK, Yeo AW, Koong HN, Ooi LL and Wong
WK: Laparotomy for acute complications of gastrointestinal
metastases from lung cancer: Is it a worthwhile or futile effort?
Surg Today. 37:370–374. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu W, Zhou W, Qi WL, Ma YD and Xu YY:
Gastrointestinal hemorrhage due to ileal metastasis from primary
lung cancer. World J Gastroenterol. 21:3435–3440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nitipir C, Ginghina O, Popa L, Andrei F,
Tudor N, Radu I, Iaciu C, Orlov C, Vasilescu F, Balalau C, et al: A
rare case of advanced lung cancer presenting as a symptomatic
gastric tumor. Mol Clin Oncol. 8:595–599. 2018.PubMed/NCBI
|
|
28
|
AlSaeed EF, Tunio MA, AlSayari K, AlDandan
S and Riaz K: Duodenal metastasis from lung adenocarcinoma: A rare
cause of melena. Int J Surg Case Rep. 13:91–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Letaief-Ksontini F, Boujnah R, Yahiaoui Y,
Zaimi Y, Ksentini M, Aloui R, Meddeb K and Mezlini A: An acute
jejunojejunal intussusception revealing a metastatic combined lung
cancer. Case Rep Surg. 2021:99996052021.PubMed/NCBI
|
|
30
|
Rittmeyer A, Barlesi F, Waterkamp D, Park
K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols
MC, et al: Atezolizumab versus docetaxel in patients with
previously treated non-small-cell lung cancer (OAK): A phase 3,
open-label, multicentre randomised controlled trial. Lancet.
389:255–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vokes EE, Ready N, Felip E, Horn L, Burgio
MA, Antonia SJ, Aren Frontera O, Gettinger S, Holgado E, Spigel D,
et al: Nivolumab versus docetaxel in previously treated advanced
non-small-cell lung cancer (CheckMate 017 and CheckMate 057):
3-year update and outcomes in patients with liver metastases. Ann
Oncol. 29:959–965. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Socinski MA, Jotte RM, Cappuzzo F, Orlandi
F, Stroyakovskiy D, Nogami N, Rodriguez-Abreu D, Moro-Sibilot D,
Thomas CA, Barlesi F, et al: Atezolizumab for First-Line Treatment
of Metastatic Nonsquamous NSCLC. N Engl J Med. 378:2288–2301. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mo H, Huang J, Xu J, Chen X, Wu D, Qu D,
Wang X, Lan B, Wang X, Xu J, et al: Safety, anti-tumour activity,
and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody
in advanced solid tumours: A dose-escalation, phase 1 study. Br J
Cancer. 119:538–545. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou C, Chen G, Huang Y, Zhou J, Lin L,
Feng J, Wang Z, Shu Y, Shi J, Hu Y, et al: Camrelizumab plus
carboplatin and pemetrexed versus chemotherapy alone in
chemotherapy-naive patients with advanced non-squamous
non-small-cell lung cancer (CameL): A randomised, open-label,
multicentre, phase 3 trial. Lancet Respir Med. 9:305–314. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hou X, Zhou C, Wu G, Lin W, Xie Z, Zhang
H, Yi J, Peng Z, Yin L, Ma C and Chen L: Efficacy, safety, and
health-related quality of life with camrelizumab plus pemetrexed
and carboplatin as first-line treatment for advanced nonsquamous
NSCLC with brain metastases (CAP-BRAIN): A multicenter, open-label,
single-arm, phase 2 study. J Thorac Oncol.
2:S1556–S0864(23)00092-8. 2023.
|
|
36
|
Ettinger DS, Wood DE, Aisner DL, Akerley
W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D'Amico
TA, et al: Non-small cell lung cancer, version 3.2022, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
20:497–530. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou C, Chen G, Huang Y, Zhou J, Lin L,
Feng J, Wang Z, Shu Y, Shi J, Hu Y, et al: Camrelizumab plus
carboplatin and pemetrexed as first-line treatment for advanced
nonsquamous NSCLC: Extended follow-up of camel phase 3 trial. J
Thorac Oncol. 13:S1556S0864(22)01993-1. 2023.
|
